232 related articles for article (PubMed ID: 32907552)
21. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
22. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
24. Survival Outcome and Clinicopathologicl analysis of Homeobox gene cluster-embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis.
Gao M; Cui Z; Li S; Li N; Tong L; Wang Y; Song M; Zhou B; Yin Z
Expert Rev Mol Diagn; 2021 Nov; 21(11):1211-1221. PubMed ID: 34410213
[TBL] [Abstract][Full Text] [Related]
25. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature.
Wang S; Zheng G; Cheng B; Chen F; Wang Z; Chen Y; Wang Y; Xiong B
PLoS One; 2014; 9(6):e99259. PubMed ID: 24901848
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
30. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis.
Yin S; Chen FF; Yang GF
Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of bromodomain protein 4 expression in solid tumor patients: A meta-analysis.
Wang Y; Wu Y; Jiang J; Zhang Y; Fu Y; Zheng M; Tao X; Yi J; Mu D; Cao X
Pathol Res Pract; 2022 Jun; 234():153918. PubMed ID: 35561521
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis.
Lu G; Cai Z; Jiang R; Tong F; Tu J; Chen Y; Fu Y; Sun J; Zhang T
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38870263
[TBL] [Abstract][Full Text] [Related]
34. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
35. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
37. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
38. High HOXD4 protein expression in gastric adenocarcinoma tissues indicates unfavorable clinical outcomes.
Liu H; Tian H; Zhao J; Jia Y
Saudi J Gastroenterol; 2019; 25(1):46-54. PubMed ID: 30588951
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
40. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.
Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y
Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
